J.L. Misset

Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil–Leucovorin as First-Line Treatment of Metastatic Colorectal Cancer

Sylvie Giacchetti, B Perpoint, Rachid Zidani et al. · Journal of Clinical Oncology · 2000 · 1.4K citations

Medicine, Oncology, Pharmacology +14

Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status.

Marie‐Christine Mormont, James Waterhouse, Pascal Bleuzen et al. · PubMed · 2000 · 435 citations

Medicine, Oncology, Chemotherapy +14

Severe CPT-11 toxicity in patients with Gilbert's syndrome: Two case reports

Ernesto Wasserman, Anne Myara, François Lokiec et al. · Annals of Oncology · 1997 · 213 citations

Pharmacy, Clinical Toxicology, Toxicologic Pathology +1

Oxalato-platinum or 1-OHP, a third-generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinum

G Mathé, Yoshinori Kidani, M. Segiguchi et al. · Biomedicine & Pharmacotherapy · 1989 · 188 citations

Medicine, Medicinal Chemistry, Oncology +5

Chemotherapy of advanced ovarian cancer with 4'-O-tetrahydropyranyl doxorubicin and cisplatin: a randomized phase II trial with an evaluation of circadian timing and dose-intensity.

Françis Lévi, Manuel Benavides, C. Chevelle et al. · Journal of Clinical Oncology · 1990 · 134 citations

Medicine, Oncology, Pharmacology +17